Asked by: Tom Morrison (Liberal Democrat - Cheadle)
Question to the Cabinet Office:
To ask the Minister for the Cabinet Office, with reference to the answer to question 42 at the Liaison Committee on 15th December 2025, whether the Prime Minister’s office has agreed a date to meet with the victims of press abuse.
Answered by Nick Thomas-Symonds - Paymaster General and Minister for the Cabinet Office
I refer the Hon Member to the answer of 02 February, Official Report, PQ 107285.
Asked by: Tom Morrison (Liberal Democrat - Cheadle)
Question to the Ministry of Justice:
To ask the Secretary of State for Justice, what steps he is taking to support Women's centres in Greater Manchester.
Answered by Jake Richards - Assistant Whip
I welcome the positive work happening in Greater Manchester to support women involved in the criminal justice system, and the work of women’s community sector organisations that provide crucial infrastructure for the criminal justice system.
His Majesty’s Prison and Probation Service (HMPPS) currently funds specialist support for women on probation through Commissioned Rehabilitative Services (CRS) delivered by third sector organisations, including providers of women’s centres. HMPPS is committed to ensuring CRS contracts deliver holistic, gender-specific support that meets women’s needs, informed by service users, stakeholders and providers.
The Ministry of Justice is providing a further £7.2 million in 2025-2026 to support the women’s community sector. This funding is aimed at building sustainability, expanding interventions and increasing capacity, including residential provision where needed. Funding for future years is subject to internal allocations.
Asked by: Tom Morrison (Liberal Democrat - Cheadle)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, how many take-home naloxone kits were distributed by local authorities in England in 2023/2024.
Answered by Sharon Hodgson - Parliamentary Under-Secretary (Department of Health and Social Care)
Access to naloxone is vital to respond to the threat of synthetic opioids and to prevent drug related deaths. The Government has long supported expanded provision of naloxone, with guidance and funding, and this has contributed to a significant growth in the amount of naloxone available in the community to reverse opioid overdoses.
In England, take-home naloxone supply is recorded by the National Drug Treatment Monitoring System, which drug and alcohol treatment services complete. It only records supply of take-home naloxone to people in registered treatment and does not record other people who may also be supplied with naloxone, like friends or family of people in treatment. Local authorities may also distribute naloxone via other routes besides substance misuse services.
We have recently published statistics on the distribution of naloxone to those in registered treatment from 2024 to 2025. The statistics can be found in the data tables in Table 1.7: naloxone distribution and use to reverse overdose, namely in Table 1.7a: naloxone issued, at the following link:
This is the first time that figures on the distribution of naloxone have been published and, therefore, trends in its distribution over time cannot yet be assessed. We intend to continue publishing statistics on naloxone distribution each year.
The Department launched a public consultation in December 2025 on further legislative options to expand access to take-home and emergency use naloxone. As part of this consultation, we are proposing specific data reporting requirements to enable more consistent reporting across the United Kingdom on the supply of take-home naloxone. The consultation closes on the 9 March 2026.
Asked by: Tom Morrison (Liberal Democrat - Cheadle)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, how many take-home naloxone kits were distributed by local authorities in England in 2024/2025.
Answered by Sharon Hodgson - Parliamentary Under-Secretary (Department of Health and Social Care)
Access to naloxone is vital to respond to the threat of synthetic opioids and to prevent drug related deaths. The Government has long supported expanded provision of naloxone, with guidance and funding, and this has contributed to a significant growth in the amount of naloxone available in the community to reverse opioid overdoses.
In England, take-home naloxone supply is recorded by the National Drug Treatment Monitoring System, which drug and alcohol treatment services complete. It only records supply of take-home naloxone to people in registered treatment and does not record other people who may also be supplied with naloxone, like friends or family of people in treatment. Local authorities may also distribute naloxone via other routes besides substance misuse services.
We have recently published statistics on the distribution of naloxone to those in registered treatment from 2024 to 2025. The statistics can be found in the data tables in Table 1.7: naloxone distribution and use to reverse overdose, namely in Table 1.7a: naloxone issued, at the following link:
This is the first time that figures on the distribution of naloxone have been published and, therefore, trends in its distribution over time cannot yet be assessed. We intend to continue publishing statistics on naloxone distribution each year.
The Department launched a public consultation in December 2025 on further legislative options to expand access to take-home and emergency use naloxone. As part of this consultation, we are proposing specific data reporting requirements to enable more consistent reporting across the United Kingdom on the supply of take-home naloxone. The consultation closes on the 9 March 2026.